Molbio Diagnostics Shares List at 21% Premium on NSE and BSE

Molbio Diagnostics shares have successfully listed on the NSE and BSE, opening at a 21% premium over their IPO price, marking a positive market entry.

17 Aug, 04:23 — 17 Aug, 04:23

Post Share

Sources

Showing 1 of 1 sources

moneycontrol11h ago

Molbio Diagnostics shares list at 21% premium over IPO price on NSE, BSE - Moneycontrol.com

Molbio Diagnostics shares list at 21% premium over IPO price on NSE, BSE Moneycontrol.com

Read full article →

PERSPECTA

PERSPECTA

Molbio Diagnostics Shares List at 21% Premium on NSE and BSE

Sources

Molbio Diagnostics shares list at 21% premium over IPO price on NSE, BSE - Moneycontrol.com

Related Stories

Dutch Sports Car Manufacturer Spyker Returns with New Model

Virgin Secures Track Access for Eurostar Rival Launch in 2030

Aston Martin Invests $2 Million in Survival Strategy

Norway Wealth Fund and ECB Warn of AI-Driven Stock Market Bubble

PERSPECTA